The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative
Open accessAbstract
Purpose: In early breast cancer (BC), five conventional biomarkers—estrogen receptor (ER), progesterone receptor (PgR), human epidermal growth factor receptor 2 (HER2), Ki67, and Nottingham histologic grade (NHG)—are used to determine prognosis and treatment. We aimed to develop classifiers for these biomarkers that were based on tumor mRNA sequencing (RNA-seq), compare classification performance, and test whether such predictors could add value for risk stratification. Methods: In total, 3,678 patients with BC were studied. For 405 tumors, a comprehensive multi-rater histopathologic evaluation was performed. Using RNA-seq data, single-gene classifiers and multigene classifiers (MGCs) were trained on consensus histopathology labels. Trained classifiers were tested on a prospective population-based series of 3,273 BCs that included a median follow-up of 52 months (Sweden Cancerome Analysis Network—Breast [SCAN-B], ClinicalTrials.gov identifier: NCT02306096), and results were evaluated by agreement statistics and Kaplan-Meier and Cox survival analyses. Results: Pathologist concordance was high for ER, PgR, and HER2 (average κ, 0.920, 0.891, and 0.899, respectively) but moderate for Ki67 and NHG (average κ, 0.734 and 0.581). Concordance between RNA-seq classifiers and histopathology for the independent cohort of 3,273 was similar to interpathologist concordance. Patients with discordant classifications, predicted as hormone responsive by histopathology but non–hormone responsive by MGC, had significantly inferior overall survival compared with patients who had concordant results. This extended to patients who received no adjuvant therapy (hazard ratio [HR], 3.19; 95% CI, 1.19 to 8.57), or endocrine therapy alone (HR, 2.64; 95% CI, 1.55 to 4.51). For cases identified as hormone responsive by histopathology and who received endocrine therapy alone, the MGC hormone-responsive classifier remained significant after multivariable adjustment (HR, 2.45; 95% CI, 1.39 to 4.34). Conclusion: Classification error rates for RNA-seq–based classifiers for the five key BC biomarkers generally were equivalent to conventional histopathology. However, RNA-seq classifiers provided added clinical value in particular for tumors determined by histopathology to be hormone responsive but by RNA-seq to be hormone insensitive.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885
High agreement but low kappa: II. Resolving the paradoxes
Cicchetti, D. V., & Feinstein, A. R. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90159-m · Cited by 1,838
Comparing two K-category assignments by a K-category correlation coefficient
Gorodkin, J. (2004) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2004.09.006 · Cited by 545
Saal, L. H., Vallon-Christersson, J., Häkkinen, J., Hegardt, C., Grabau, D., Winter, C., Brueffer, C., Tang, M.-H. E., Reuterswärd, C., Schulz, R., et al. (2015) · Genome Medicine · doi:10.1186/s13073-015-0131-9 · Cited by 255
Self-citation
Research works printed but not linked: 32
- 10.6004/jnccn.2014.0058 · DOI · Paper page
- 10.1093/annonc/mdv298 · DOI · Paper page
- 10.1200/JCO.2009.25.6529 · DOI · Paper page
- 10.1158/1078-0432.CCR-05-0636 · DOI · Paper page
- 10.1200/JCO.2005.03.4744 · DOI · Paper page
- 10.1080/02841860902862511 · doi:10.1080/02841860902862511
- 10.3109/0284186X.2015.1037012 · doi:10.3109/0284186x.2015.1037012
- 10.1200/JCO.2013.50.9984 · DOI · Paper page
- 10.1093/jnci/djr393 · DOI · Paper page
- 10.1093/jnci/djt306 · DOI · Paper page
- 10.1159/000430488 · doi:10.1159/000430488
- 10.1186/bcr2607 · DOI · Paper page
- 10.1073/pnas.0702507104 · DOI · Paper page
- 10.1200/JCO.2008.18.1370 · DOI · Paper page
- 10.1158/1078-0432.CCR-09-0449 · DOI
- Häkkinen J, bioRxiv
- 10.1073/pnas.082099299 · DOI · Paper page
- Viera AJ, 2005, Fam Med, 37, 360
- 10.1371/journal.pone.0082144 · doi:10.1371/journal.pone.0082144
- 10.1093/hmg/ddg347 · DOI
- 10.1093/annonc/mdu026 · DOI
- 10.1007/s10549-014-3163-8 · DOI
- 10.1101/gr.189621.115 · DOI · Paper page
- 10.1126/scitranslmed.3003161 · DOI · Paper page
- 10.1056/NEJMoa1602253 · DOI · Paper page
- 10.1080/028418600430950 · DOI
- 10.1186/bcr2257 · DOI · Paper page
- 10.1038/srep38037 · DOI
- Dhondalay GK, 2011, Proc Int Conf Mach Learn Cybern, 2, 727
- 10.1056/NEJMoa041588 · DOI · Paper page
- 10.1158/0008-5472.CAN-05-4414 · DOI · Paper page
- 10.1093/jnci/djj052 · DOI · Paper page
Cited by
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
Staaf, J., Glodzik, D., Bosch, A., Vallon-Christersson, J., Reuterswärd, C., Häkkinen, J., Degasperi, A., Amarante, T. D., Saal, L. H., Hegardt, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0582-4 · Cited by 307
“Gene expression profiling of all TNBCs were performed using RNA sequencing as described 33 and data has been reported elsewhere 35 .”
Self-citationLimenih, Y. A., & Workie, D. L. (2019) · BMC Public Health · doi:10.1186/s12889-019-6500-3 · Cited by 27
Metadata
- Authors
- Brueffer, C., Vallon-Christersson, J., Grabau, D., Ehinger, A., Häkkinen, J., Hegardt, C., Malina, J., Chen, Y., Bendahl, P.-O., Manjer, J., Malmberg, M., Larsson, C., Loman, N., Rydén, L., Borg, Å., & Saal, L. H.
- Venue
- JCO Precision Oncology
- Published
- 2018-11
- Volume
- 2
- Issue
- 2
- Pages
- 1-18
- ISSN
- 2473-4284 (ISSN-L)
- OpenAlex
- W2792135005
- Cited by
- 218
- References
- 6
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative. https://app.cochat.ai/papers/10.1200/po.17.00135
- The paper
- Brueffer, C., Vallon-Christersson, J., Grabau, D., Ehinger, A., Häkkinen, J., Hegardt, C., Malina, J., Chen, Y., Bendahl, P.-O., Manjer, J., Malmberg, M., Larsson, C., Loman, N., Rydén, L., Borg, Å., & Saal, L. H. (2018). Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative. JCO Precision Oncology. https://doi.org/10.1200/po.17.00135
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.